12 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

SPOTFIRE RSP Pos & Neg Controls; SPOTFIRE RSP Negative Control

FDA 510(k)
FDA Class 2 ·Microbiology

LCP

FDA UDI
Synthes GmbH·10886982166654·3.5MM LCP® MEDIAL DISTAL HUMERUS PLATE 9 HOLES-...

TALUS OF VILEX (TOV)

FDA 510(k)
FDA Class 2 ·Orthopedic

TC-THUNDERBOLT AUTOMATED URINE ANALYZER SYSTEM AND TC-THUNDERBOLT URS-10 STRIPS

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

PUMP MMT-1780KPK 670G PATHWAY BLACK MG

FDA Adverse Event
Injury ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code OZP·July 13, 2018

ANGIO-SEAL DEVICE

FDA Adverse Event
Injury ·ST. JUDE MEDICAL·Product code MGB·November 20, 2008

STENOSCOP

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·August 17, 2011

SECURE II MED/SURG BED

FDA Adverse Event
Malfunction ·STRYKER MEDICAL-KALAMAZOO·Product code FNL·July 22, 2013

ARCOS 17X150MM SPL TPR DIST

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWA·June 12, 2024

ARCOS CON SZ C STD 60MM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWA·June 12, 2024

IMP,TSV,4.7,8,MTX,MG

FDA Adverse Event
Injury ·ZIMMER DENTAL·Product code DZE·February 1, 2023

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014